Employer-incurred health care costs and productivity losses associated with influenza

Human Vaccines and Immunotherapeutics

Volumn 9, Issue 4, 2013, Pages 841-857

  Karve, Sudeep ^a   Misurski, Derek A ^b   Meier, Genevieve ^b   Davis, Keith L ^a  

^a RTI HEALTH SOLUTIONS   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

Employer burden; Health care cost; Influenza; Productivity

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; EMERGENCY WARD; EMPLOYER; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL CARE; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PRESCHOOL CHILD; PRODUCTIVITY; RESOURCE ALLOCATION; RETROSPECTIVE STUDY; SCHOOL CHILD; SEASONAL INFLUENZA;

EMPLOYER BURDEN; HEALTH CARE COST; INFLUENZA; PRODUCTIVITY;

ABSENTEEISM; EMPLOYER HEALTH COSTS; FEMALE; HUMANS; INCIDENCE; INFLUENZA, HUMAN; LONGITUDINAL STUDIES; MALE; RETROSPECTIVE STUDIES;

EID: 84877155795     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.23413     Document Type: Article

References (46)

1. Centers for Disease Control and Prevention. Influenza: the disease: the flu season. 2010a. Available at: http://www.cdc.gov/flu/about/season/flu-season. htm.AccessedSeptember13, 2010.
2. Lee PY, Matchar DB, Clements DA, Huber J, Hamilton JD, Peterson ED. Economic analysis of influenza vaccination and antiviral treatment for healthy working adults. Ann Intern Med 2002; 137: 225-31; PMID:12186512.
3. Lofgren E, Fefferman NH, Naumov YN, Gorski J, Naumova EN. Influenza seasonality: underlying causes and modeling theories. J Virol 2007; 81:5429-36; PMID:17182688; http://dx.doi.org/10.1128/JVI.01680-06.
4. Centers for Disease Control and Prevention. 2009 H1N1-related deaths, hospitalizations and cases: details of extrapolations and ranges: United States. Emerging Infections Program (EIP) data. 2010b. Available at: http://www.cdc.gov/h1n1flu/estimates-2009-h1n1.htm/.Accessed20July2012.
5. Centers for Disease Control and Prevention (CDC). Estimates of deaths associated with seasonal influenza-United States, 1976-2007. MMWR Morb Mortal Wkly Rep 2010c;59:1057-62; PMID:20798667.
6. Akazawa M, Sindelar JL, Paltiel AD. Economic costs of influenza-related work absenteeism. Value Health 2003; 6:107-15; PMID:12641861; http://dx.doi.org/10.1046/j.1524-4733.2003.00209.x.
7. Keech M, Scott AJ, Ryan PJ. The impact of influenza and influenza-like illness on productivity and healthcare resource utilization in a working population. Occup Med (Lond) 1998; 48:85-90; PMID:9614766; http://dx.doi.org/10. 1093/occmed/48.2.85.
8. Keech M, Beardsworth P. The impact of influenza on working days lost: a review of the literature. Pharmacoeconomics 2008; 26:911-24; PMID:18850761; http://dx.doi.org/10.2165/00019053-200826110-00004.
9. Nichol KL, D'Heilly SJ, Greenberg ME, Ehlinger E. Burden of influenza-like illness and effectiveness of influenza vaccination among working adults aged 50-64 years. Clin Infect Dis 2009; 48:292-8; PMID:19115970; http://dx.doi.org/10.1086/595842.
10. Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 2007; 25:5086-96; PMID:17544181; http://dx.doi.org/10.1016/j.vac-cine.2007.03.046.
11. Huse DM, Marder WD. Recent trends in employer health care spending by disease: research podium abstracts. Value Health 2010; 13:A8; http://dx.doi.org/10.1016/S1098-3015(10)72022-2.
12. Centers for Disease Control and Prevention (CDC). Influenza activity-United States and worldwide, 2007-08 season. MMWR Morb Mortal Wkly Rep 2008; 57:692-7; PMID:18583957.
13. Centers for Disease Control and Prevention (CDC). Update: influenza activity-United States, August 30-October 31, 2009. MMWR Morb Mortal Wkly Rep 2009; 58:1236-41; PMID:19910911.
14. Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 2010; 375:1100-8; PMID:20096450; http://dx.doi.org/10.1016/S0140-6736(09)62126-7.
15. Reed C, Angulo FJ, Swerdlow DL, Lipsitch M, Meltzer MI, Jernigan D, et al. Estimates of the prevalence of pandemic (H1N1) 2009, United States, April-July 2009. Emerg Infect Dis 2009; 15:2004-7; PMID:19961687; http://dx.doi.org/10.3201/eid1512.091413.
16. Shrestha SS, Swerdlow DL, Borse RH, Prabhu VS, Finelli L, Atkins CY, et al. Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010). Clin Infect Dis 2011; 52(Suppl 1):S75-82; PMID:21342903; http://dx.doi.org/10.1093/cid/ciq012.
17. Belongia EA, Kieke BA, Donahue JG, Greenlee RT, Balish A, Foust A, et al.; Marshfield Influenza Study Group. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J Infect Dis 2009; 199:159-67; PMID:19086915; http://dx.doi.org/10.1086/595861.
18. Reed C, Meltzer MI, Finelli L, Fiore A. Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine. Vaccine 2012; 30:1993-8; PMID:22226861; http://dx.doi.org/10.1016/j.vaccine. 2011.12.098.
19. Belshe RB. The need for quadrivalent vaccine against seasonal influenza. [review]. Vaccine 2010; 28(Suppl 4):D45-53; PMID:20713260; http://dx.doi.org/10. 1016/j.vaccine.2010.08.028.
20. Cox F, Khan ZM, Schweinle JE, Okamoto L, McLaughlin T. Cost associated with the treatment of influenza in a managed care setting. MedGenMed 2000; 2:E34; PMID:11104480.
21. Fairbrother G, Cassedy A, Ortega-Sanchez IR, Szilagyi PG, Edwards KM, Molinari NA, et al.; New Vaccine Surveillance Network (NVSN). High costs of influenza: Direct medical costs of influenza disease in young children. Vaccine 2010; 28:4913-9; PMID:20576536; http://dx.doi.org/10.1016/j.vaccine.2010.05.036.
22. Galante M, Garin O, Sicuri E, Cots F, García-Altés A, Ferrer M, et al. Health services utilization, work absenteeism and costs of pandemic influenza A (H1N1) 2009 in Spain: a multicenter-longitudinal study. PLoS One 2012; 7:e31696; PMID:22348122; http://dx.doi.org/10.1371/journal.pone. 0031696.
23. Zarogoulidis P, Glaros D, Kontakiotis T, Froudarakis M, Kioumis I, Kouroumichakis I, et al. Health costs from hospitalization with H1N1 infection during the 2009-2010 influenza pandemic compared with non-H1N1 respiratory infections. Int J Gen Med 2012; 5:175-82; PMID:22419882; http://dx.doi.org/10. 2147/IJGM.S28454.
24. Irwin DE, Weatherby LB, Huang WY, Rosenberg DM, Cook S F, Walker AM. Impact of patient characteristics on the risk of influenza/ILI-related complications. BMC Health Serv Res 2001; 1:8; PMID:11580874; http://dx.doi.org/10.1186/1472-6963-1-8.
25. Shattuck A. Older Americans Working More, Retiring Less. 2012 Available at: http://www.carseyinstitute.unh.edu/publications/IB-Shattuck-Older-Workers. pdf.Accessed:20July2012.
26. Centers for Disease Control and Prevention. Influenza vaccination: a summary for clinicians. 2011. Available at: http://www.cdc.gov/flu/ professionals/vaccination/vax-summary.htm.Accessed:20July2012.
27. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12:36-44; PMID:22032844; http://dx.doi.org/10.1016/ S1473-3099(11)70295-X.
28. Kelly H, Carville K, Grant K, Jacoby P, Tran T, Barr I. Estimation of influenza vaccine effectiveness from routine surveillance data. PLoS One 2009; 4:e5079; PMID:19333374; http://dx.doi.org/10.1371/journal.pone.0005079.
29. Campbell DS, Rumley MH. Cost-effectiveness of the influenza vaccine in a healthy, working-age population. J Occup Environ Med 1997; 39:408-14; PMID:9172085; http://dx.doi.org/10.1097/00043764-199705000-00006.
30. Lee BY, Brown ST, Cooley PC, Zimmerman RK, Wheaton WD, Zimmer SM, et al. A computer simulation of employee vaccination to mitigate an influenza epidemic. Am J Prev Med 2010; 38:247-57; PMID:20042311; http://dx.doi.org/10.1016/j. amepre.2009.11.009.
31. Samad AH, Usul MH, Zakaria D, Ismail R, Tasset-Tisseau A, Baron-Papillon F, et al. Workplace vaccination against influenza in Malaysia: does the employer benefit? J Occup Health 2006; 48:1-10; PMID:16484757; http://dx.doi.org/10. 1539/joh.48.1.
32. Burckel E, Ashraf T, de Sousa Filho J P, Forleo Neto E, Guarino H, Yauti C, et al. Economic impact of providing workplace influenza vaccination. A model and case study application at a Brazilian pharma-chemical company. Pharmacoeconomics 1999; 16:563-76; PMID:10662481; http://dx.doi.org/10.2165/ 00019053-199916050-00012.
33. Das Gupta R, Guest J F. A model to estimate the cost benefit of an occupational vaccination programme for influenza with Influvac in the UK. Pharmacoeconomics 2002; 20:475-84; PMID:12093303; http://dx.doi.org/10.2165/ 00019053-200220070-00005.
34. Gatwood J, Meltzer MI, Messonnier M, Ortega-Sanchez IR, Balkrishnan R, Prosser LA. Seasonal influenza vaccination of healthy working-age adults: a review of economic evaluations. Drugs 2012; 72:35-48; PMID:22191794; http://dx.doi.org/10.2165/11597310-000000000-00000.
35. Morales A, Martinez MM, Tasset-Tisseau A, Rey E, Baron-Papillon F, Follet A. Costs and benefits of influenza vaccination and work productivity in a Colombian company from the employer's perspective. Value Health 2004; 7:433-41; PMID:15449635; http://dx.doi.org/10.1111/j.1524-4733.2004.74006.x.
36. Cohen GM, Nettleman MD. Economic impact of influenza vaccination in preschool children. Pediatrics 2000; 106:973-6; PMID:11061762; http://dx.doi.org/10.1542/peds.106.5.973.
37. Luce BR, Zangwill KM, Palmer CS, Mendelman PM, Yan L, Wolff MC, et al. Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children. Pediatrics 2001; 108:E24; PMID:11483834; http://dx.doi.org/10.1542/peds.108.2.e24.
38. Salo H, Kilpi T, Sintonen H, Linna M, Peltola V, Heikkinen T. Cost-effectiveness of influenza vaccination of healthy children. Vaccine 2006; 24:4934-41; PMID:16678945; http://dx.doi.org/10.1016/j.vac-cine.2006.03.057.
39. White T, Lavoie S, Nettleman MD. Potential cost savings attributable to influenza vaccination of school-aged children. Pediatrics 1999; 103:e73; PMID:10353970; http://dx.doi.org/10.1542/peds.103.6.e73.
40. Izurieta HS, Thompson WW, Kramarz P, Shay DK, Davis RL, DeStefano F, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 2000; 342:232-9; PMID:10648764; http://dx.doi.org/10.1056/NEJM200001273420402.
41. Lin JC, Nichol KL. Excess mortality due to pneumonia or influenza during influenza seasons among persons with acquired immunodeficiency syndrome. Arch Intern Med 2001; 161:441-6; PMID:11176770; http://dx.doi.org/10.1001/archinte. 161.3.441.
42. Cortes JE, Curns AT, Tate JE, Cortese MM, Patel MM, Zhou F, et al. Rotavirus vaccine and health care utilization for diarrhea in U.S. children. N Engl J Med 2011; 365:1108-17; PMID:21992123; http://dx.doi.org/10.1056/ NEJMoa1000446.
43. Piedra PA, Schulman KL, Blumentals WA. Effects of oseltamivir on influenza-related complications in children with chronic medical conditions. Pediatrics 2009; 124:170-8; PMID:19564297; http://dx.doi.org/10.1542/peds.2008- 0977.
44. US Census Bureau. Labor force, employment, and earnings. 2012. Available at: http://www.census.gov/compendia/statab/cats/labor-force-employment-earn- ings.html.Accessed20July2012.
45. Rothman KJ, Boice JD Jr. Epidemiologic analysis with a programmable calculator (NIH Publication 79-1649). Washington DC: US Government Printing Office. 1979. Available at: http://www.epidemiolog.net/studymat/. Accessed20July2012.
46. Schanzer DL, Langley JM, Tam TW. Co-morbidities associated with influenza-attributed mortality, 1994-2000, Canada. Vaccine 2008; 26:4697-703; PMID:18620016.